期刊文献+

鼻咽癌放疗后吸入性肺炎早期纤维支气管镜治疗效果观察

Therapeutic value of early bronchoscopy in aspiration pneumonia patients after nasopharyngeal carcinoma radiotherapy
原文传递
导出
摘要 回顾性分析2005年1月至2010年12月住院治疗的41例患者,均为鼻咽癌放疗后合并吸入性肺炎者,其中早期纤维支气管镜治疗组24例(A组),单纯常规治疗组17例(B组)。分析早期纤维支气管镜治疗对鼻咽癌放疗后吸入性肺炎患者体温、血象、影像学肺部吸收和死亡率的影响。治疗前A组与B组的体温和血WBC处于同一水平[(38.7±0.7)℃与(38.5±0.7)℃,P=0.633;(15.8±4.2)×109/L与(16.2±3.4)×109/L,P=0.430],治疗3d后两组体温差异具有统计学意义[(37.3±0.9)℃与(38.4±1.4)℃,P=0.015];治疗5d后两组白细胞差异有统计学意义[(10.6±4.2)×109/L与(15.3±6.9)×109/L,P=0.045];A组肺部影像学改变较常规组吸收更快(z=-3.515,P=0.00),两组死亡率没有统计学差异。 A total of 41 patients with aspiration pneumonia after nasopharyngeal carcinoma radiotherapy were retrospectively selected from January 2005 to December 2010. They were divided into early bronehoscopy group (n = 24) and conventional therapy group (n = 17) to analyze the therapeutic effects of early bronehoscopy on temperature, white blood cell (WBC) , absorption of chest radiography and mortality rates. The temperature and WBC were at the same level between both groups at pre-treatment [ (38.7 ± 0.7)℃ vs. (38.5±0.7)℃, P=0.633; (15.8±4.2) ×l09/Lvs. (16.2 ±3.4) ×l09/L, P=0.430] while the temperature declined obviously after a 3-day treatment [ (37.3±0. 9) ℃ vs. (38.4 ± 1.4) ℃, P = 0. 015 ] and also WBC after a 5-day treatment[(10. 6±4.2) ×109/L vs. (15.3 ±6.9)× 109/L, P= 0. 045]. The bronehoscopy group had a faster absorption of chest radiography (Z = -3. 515, P =0. 00). The mortality rate showed no statistically significant difference between both groups.
出处 《中华全科医师杂志》 2012年第10期774-775,共2页 Chinese Journal of General Practitioners
关键词 肺炎 吸入性 支气管镜 Pneumonia, aspiration Bronchoscopes
  • 相关文献

参考文献7

二级参考文献32

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:787
  • 3王洪冰,李佩珍.老年人吸入性肺炎的诊治难点和对策[J].中华老年医学杂志,2006,25(5):325-327. 被引量:83
  • 4Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 5de Roux A,Marcos MA,Garcia E,et al.Viral community-acquired pneumonia in nonimmunocompromised adults.Chest,2004,125:1343-1351.
  • 6Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659.
  • 7Food and Drug Administration,HHS.Class Ⅱ Special Controls Guidance Document:serological assays for the detection of betaglucan.Fed Reqist,2004,69:56934-56936.
  • 8Mandell LA,Marrie TJ,Grossman RF,et al.Canadian guidelines for the initial management of community-acquired pneumonia:an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society.The Canadian CommunityAcquired Pneumonia Working Group.Clin Infect Dis,2000,31:383-421.
  • 9Woodhead M,Blasi F,Ewig S,et al.Guidelines for the management of adult lower respiratory tract infections.Eur Respir J,2005,26:1138-1180.
  • 10Mandell LA,Bartlett JG,Dowell SF,et al.Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.Clin Infect Dis,2003,37:1405-1433.

共引文献3443

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部